Testing new coronavirus vaccines in early clinical trials
Official title: Phase 1 and Phase 2 Clinical Trials for Next-Generation Coronavirus Vaccines
Funded at Leidos Biomedical Research, INC. · NIH-11042071 · Data updated 2026-11-12
This study is testing new coronavirus vaccines to see how safe and effective they are, and it's looking for people to join who want to help find better ways to protect against COVID-19.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Leidos Biomedical Research, INC. NIH-funded |
| Lab location | 1 site (Frederick, United States) |
| Project start | June 1, 2023 |
| Project end | May 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $15,048,720 |
| NIH project number | 75N91019D00024-P00001-759102300008-1 |
| Project ID | NIH-11042071 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation include adults who are at risk of coronavirus infection or those who are interested in contributing to vaccine development.
✕Less likely to help
Patients who are not at risk for coronavirus or those who have already received a vaccine may not benefit from this research.
What this research studies
This research focuses on conducting early-phase clinical trials to evaluate next-generation coronavirus vaccines. Patients will be involved in trials that assess the safety and effectiveness of these new vaccine candidates. The trials will follow standardized protocols to ensure reliable data is collected, which will help determine which vaccines should be advanced for further development. Participants may receive either the vaccine candidate or a placebo as part of the trial process.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective vaccines against coronavirus, improving public health outcomes.
How similar studies have gone: Previous clinical trials for coronavirus vaccines have shown success, indicating that this approach is promising and builds on established methodologies.
Where this research is happening
-
Leidos Biomedical Research, INC.
Frederick, United States Active
Researchers
- Principal investigator: Datta, Kiran — Leidos Biomedical Research, INC.
- Study coordinator: Datta, Kiran
Related research
Other NIH-funded projects on the same topics.
-
Improving public health responses to COVID-19 through standardized testing.
This study is looking to improve how we fight COVID-19 by testing blood samples to see if people have had the virus, and it’s designed for anyone interested in better ways to manage the disease.
-
Creating a large library of cancer models for research use
This study is creating a collection of new cancer models to help researchers and companies find better ways to treat cancer, making it easier for everyone to work together and share ideas.
-
Advancing global cancer control through data analysis and international collaboration
This study is all about helping countries around the world work better together to fight cancer by sharing important information and training scientists, especially in places that need extra support.
-
Support for HIV and HPV cancer prevention clinical trials in the Americas
This study is working on new vaccines and treatments to help prevent cancers related to HIV and HPV, making sure that patients in the US, Latin America, and the Caribbean can access better options as these exciting trials move forward.
-
Development and production of clinical-grade biopharmaceuticals
This study is all about making safe and effective new medicines, like vaccines and treatments for various conditions, so that patients can have access to the latest therapies that meet high-quality standards.
-
Understanding the immune response to COVID-19
This study is looking for ways to improve COVID-19 testing and understand how our immune system fights the virus, and you can help by sharing samples to make these tests better for everyone.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.